Molecule intelOpportunity: Lower0

Levobunolol

14 brands · 11 companies · product forms

Opportunity snapshot

Launch attractiveness
12
Market saturation
29
Price room
0
Regulatory risk
0
14
brands
11
companies
Rs 123.07
median price
2
price points
1x
price spread
65
confidence %

Who competes here

Top companies by brand count · leader share 21%

Price room

Across observed sources and strengths
CheapestRs 123.07
MedianRs 123.07
Most expensiveRs 123.07
Spread1×
Sources: DRAP-official, Servaid

Only 2 trusted price points; variation not scored (low data).

Brands & products on the market

Sample of 1 live product for Levobunolol — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(0) + 20% low-competition(71) + 15% supply-disruption(0), damped by confidence(65). Higher = more attractive, less crowded opportunity.

Market saturation

11 canonical companies and 14 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 2 trusted price points; variation not scored (low data).

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: sparse price data, no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.